Rheumnow Podcast

Dr. Jack Cush goes off on "Untitling" (not using proper names/titles) in the clinic, in additon to reports on rheumatologist salaries, new drugs in phase 1-3 development and the range of COVID-19 MSK symptoms -- all from the past week on RheumNow.com.

Drs. Pendleton Wickersham (Arthritis Associates PA, San Antonio, TX), Kevin Winthrop (OHSU, Portland, OR), and Christopher Ritchlin (URMC, Rochester, NY) come together to share their experiences discussing with patients the benefit-risk of a JAK inhibitor.

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.

Thanks to all of you for your kind comments and great reviews of our weekly podcast. Please let us know how we can improve by emailing me (jackcush@rheumnow.com) or recording your suggestion using the "Ask Cush Anything" link on our email and website.

Dr. Jack Cush reviews the news, journal reports, ACR and FDA announcements from the past week on RheumNow.com

Can we predict the bad outcomes? Like when ITP evolves into SLE; or when psoriasis will develop arthritis; or if  Sjogens will develop lymphoma?  Dr. Jack Cush reviews these journal reports and this past weeks news from RheumNow.com

Featuring a discussion with Dr. Susan Shenoi from Seattle Childrens Hospital

Dr. Jack Cush discusses declining survival rates in the USA, FDA approvals of new COVID subvariant boosters and other odd and possibly true new research reports from the past week on RheumNow.com.

Rainbow Rheumatology (8.26.2022) Dr. Jack Cush delivers this weeks rheumatology "weather report" with the best and least of news and journal articles from the past week on RheumNow.com “Climate is what we expect, weather is what we get.” – Mark Twain

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow and discusses a case of refractory juvenile dermatomyositis with calcinosis.